ArticleWorld journal of microbiology & biotechnology2026
Deciphering the potential antagonistic activity of Bacillus velezensis GNB3-7 against Astragalus mongholicus root rot.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Astragalus mongholicus is one of the most commonly traditional Chinese herbal medicines in China and other Asian countries. However, the root rot disease caused by Fusarium oxysporum can severely reduce root yield and quality, resulting in significant large economic losses. Although biological control has attracted widespread attention due to its safety, environmental friendliness and sustainability, the biocontrol efficiency and potential mechanism of Bacillus velezensis against root rot of A. mongholicus have been rarely investigated. In the present study, a rhizosphere bacterium GNB3-7 was isolated from the rhizosphere soil of wild A. mongholicus and possessed the strong broad-spectrum antagonistic activity on multiple pathogenic fungi, which was identified as B. velezensis on the basis of whole-genome sequence analyses. Further genomic analyses revealed that the B. velezensis GNB3-7 has 12 biosynthetic gene clusters encoding antifungal secondary metabolites (e.g., surfactin, bacillibactin, bacilysin). In addition, a total of 36 volatile organic compounds (VOCs) were detected by GC-MS, among which benzothiazole, disulfide-dimethyl and 2-nonanone showed the strongest antifungal activities, with an inhibition rate of 99.41%, 96.87% and 92.69%, respectively. In pot experiments, the treatment rate and prevention efficiency of B. velezensis GNB3-7 against A. mongholicus root rot achieved 44.44% and 72.22%, respectively. Notably, the genes involved in plant induced systemic resistance (ISR, e.g., AmNPR1, AmCHI2 and AmCOI1) were significantly up-regulated in treatment and prevention plants, indicating the activation of ISR in A. mongholicus. These results indicated that B. velezensis GNB3-7 could efficiently control root rot by synergistic action involving the production of metabolites and VOCs, activation of plant ISR, which deepens our understanding on the biocontrol mechanism of B. velezensis against root rot in medicinal plant A. mongholicus.
Indexed as
Identifiers
42801409What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.